Physician

Joseph R Arulandu, MD

According to 2025 Medicare claims, Joseph Arulandu, MD (NPI: 1316952807) practices internal medicine in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is LA PORTE CLINIC COMPANY LLC (NPI: 1568829224; TIN: 810745237) and primary practice location at 46360-9198. Arulandu is affiliated with the CHSPSC ACO 21, LLC (ACO ID: A3698), participating under the MSSP model.

Arulandu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 484 traditional Medicare patients, billed 2,809 HCPCS/CPT codes, and received $129,097 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 19,424 prescription claims across 929 beneficiaries totaling $1,682,620 in drug costs, led by Ozempic (Semaglutide). DME data shows 652 claims. Open Payments data shows 194 records totaling $4,505. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,061,076 to $1,682,620. For DME billing, reported payments rose steadily, from $44,324 to $55,970.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	769	24,552	$131,046
2016	750	21,008	$128,168
2017	717	3,725	$120,467
2018	724	3,517	$105,438
2019	704	3,515	$115,649
2020	627	2,885	$98,544
2021	567	3,064	$117,634
2022	532	2,720	$127,593
2023	504	2,590	$128,569
2024	484	2,809	$129,097

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	819	15,553	$1,061,076
2016	843	16,116	$1,183,031
2017	834	17,424	$1,286,092
2018	934	18,622	$1,452,263
2019	961	18,950	$1,589,374
2020	930	18,685	$1,574,578
2021	913	18,719	$1,625,926
2022	957	19,109	$1,698,807
2023	919	19,416	$1,770,253
2024	929	19,424	$1,682,620

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	382	1,188	$51,192
2016	328	1,308	$44,523
2017	303	1,039	$39,566
2018	277	990	$36,475
2019	319	1,052	$43,701
2020	334	953	$46,961
2021	248	822	$43,097
2022	195	759	$56,824
2023	127	740	$65,478
2024	185	652	$55,942

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	323	323	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	488	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	357	699	$52
83036	Hemoglobin a1c level	168	324	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	163	313	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	142	6,566	$204,415
Trulicity	Dulaglutide	147	4,984	$165,281
Jardiance	Empagliflozin	139	8,601	$163,763
Farxiga	Dapagliflozin Propanediol	107	5,730	$105,125
Eliquis	Apixaban	100	5,269	$98,486

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	59	$22,447
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	17	$7,593
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	18	$6,105
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	16	$3,172
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	47	$3,046

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	194	$4,505	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph R. Arulandu, MD?

Tedicare shows public-source Medicare data for Joseph R. Arulandu, MD (NPI 1316952807), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph R. Arulandu, MD have ACO affiliation data?

Joseph R. Arulandu, MD is shown with ACO affiliation data for CHSPSC ACO 21, LLC (MSSP, ACO ID A3698).

What billing organization is linked to Joseph R. Arulandu, MD?

Joseph R. Arulandu, MD is linked to LA PORTE CLINIC COMPANY LLC (billing NPI 1568829224) in the available physician profile data.

Does Joseph R. Arulandu, MD have Open Payments data?

Joseph R. Arulandu, MD has 194 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.